Literature DB >> 5762885

Studies in kernicterus. II. The determination of the saturation of serum albumin with bilirubin.

G B Odell, S N Cohen, P C Kelly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5762885     DOI: 10.1016/s0022-3476(69)80069-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  8 in total

1.  Development of a spin assay for reserve bilirubin loading capacity of human serum.

Authors:  J C Hsia; N H Kwan; S S Er; D J Wood; G W Chance
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Assessing the risk of kernicterus.

Authors:  H Nakamura
Journal:  Indian J Pediatr       Date:  1987 Sep-Oct       Impact factor: 1.967

3.  Clinical evaluation of Sephadex gel filtration in estimation of bilirubin binding in serum in neonatal jaundice.

Authors:  J Kapitulnik; T Valaes; N A Kaufmann; S H Blondheim
Journal:  Arch Dis Child       Date:  1974-11       Impact factor: 3.791

4.  Comparative analysis between albumin-binding capacity and the concentration of unbound bilirubin in hyperbilirubinemic sera of newborn infants.

Authors:  J Frenzel; I Sander; D Schramm
Journal:  Z Kinderheilkd       Date:  1973-08-31

5.  Reserve albumin binding capacity, salicylate saturation index, and red cell binding of bilirubin in neonatal jaundice.

Authors:  D Bratlid
Journal:  Arch Dis Child       Date:  1973-05       Impact factor: 3.791

Review 6.  Neonatal bilirubin toxicity. A review of kernicterus and the implications of drug-induced bilirubin displacement.

Authors:  P C Walker
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

7.  Effect of drugs on urate binding to plasma proteins.

Authors:  R Bluestone; I Kippen; J R Klinenberg
Journal:  Br Med J       Date:  1969-12-06

Review 8.  Review of bilirubin neurotoxicity I: molecular biology and neuropathology of disease.

Authors:  Sean M Riordan; Steven M Shapiro
Journal:  Pediatr Res       Date:  2019-10-10       Impact factor: 3.756

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.